Systemic Immune-Inflammation Index Predicts Long-Term Outcomes in Patients with Three-Vessel Coronary Disease After Revascularization: Results from a Large Cohort of 3561 Patients

References

• Bradley SM, Spertus JA, Kennedy KF, et al. Patient selection for diagnostic coronary angiography and hospital-level percutaneous coronary intervention appropriateness: insights from the National Cardiovascular Data Registry. JAMA Intern Med. 2014;174(10):1630–1639. doi:10.1001/jamainternmed.2014.3904
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhu Y, Wang J, et al. Gender-based long-term outcomes after revascularization for three-vessel coronary disease: a propensity score-matched analysis of a large cohort. Clin Interv Aging. 2022;17:545–554. doi:10.2147/CIA.S362027
   PubMed Web of Science ®Google Scholar
• Thuijs DJ, Kappetein AP, Serruys PW, et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. Lancet. 2019;394(10206):1325–1334. doi:10.1016/S0140-6736(19)31997-X
   PubMed Web of Science ®Google Scholar
• Han YC, Yang TH, Kim DI, et al. Neutrophil to lymphocyte ratio predicts long-term clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Korean Circ J. 2013;43(2):93–99. doi:10.4070/kcj.2013.43.2.93
   PubMed Web of Science ®Google Scholar
• Arbel Y, Finkelstein A, Halkin A, et al. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis. 2012;225(2):456–460. doi:10.1016/j.atherosclerosis.2012.09.009
   PubMed Web of Science ®Google Scholar
• Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212–6222. doi:10.1158/1078-0432.CCR-14-0442
   PubMed Web of Science ®Google Scholar
• Yang R, Chang Q, Meng X, Gao N, Wang W. Prognostic value of Systemic immune-inflammation index in cancer: a meta-analysis. J Cancer. 2018;9(18):3295–3302. doi:10.7150/jca.25691
   PubMed Web of Science ®Google Scholar
• Luo Y, Zhang J, Liu T, et al. The systemic-immune-inflammation index predicts the recurrence of atrial fibrillation after cryomaze concomitant with mitral valve surgery. BMC Cardiovasc Disord. 2022;22(1):45. doi:10.1186/s12872-022-02494-z
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu W, Yu H, et al. Value of the Systemic Immune-Inflammatory Index (SII) in predicting the prognosis of patients with peripartum cardiomyopathy. Front Cardiovasc Med. 2022;9:811079. doi:10.3389/fcvm.2022.811079
   PubMed Web of Science ®Google Scholar
• Seo M, Yamada T, Morita T, et al. P589Prognostic value of systemic immune-inflammation index in patients with chronic heart failure. Eur Heart J. 2018;39:ehy564.P589.
   PubMed Web of Science ®Google Scholar
• Min JK, Dunning A, Lin FY, et al. Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the international multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: an International Multicenter Registry) of 23,854 patients without known coronary artery disease. J Am Coll Cardiol. 2011;58(8):849–860. doi:10.1016/j.jacc.2011.02.074
   PubMed Web of Science ®Google Scholar
• Zhao X, Jiang L, Xu L, et al. Predictive value of in-hospital white blood cell count in Chinese patients with triple-vessel coronary disease. Eur J Prev Cardiol. 2019;26(8):872–882. doi:10.1177/2047487319826398
   PubMed Web of Science ®Google Scholar
• Leu HB, Yin WH, Tseng WK, et al. Identification of new biosignatures for clinical outcomes in stable coronary artery disease - The study protocol and initial observations of a prospective follow-up study in Taiwan. BMC Cardiovasc Disord. 2017;17(1):42. doi:10.1186/s12872-017-0471-z
   PubMed Web of Science ®Google Scholar
• Yang YL, Wu CH, Hsu PF, et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020;50(5):e13230. doi:10.1111/eci.13230
   PubMed Web of Science ®Google Scholar
• Guo L, Wang J, Ding H, et al. Long-term outcomes of medical therapy versus successful recanalisation for coronary chronic total occlusions in patients with and without type 2 diabetes mellitus. Cardiovasc Diabetol. 2020;19(1):100. doi:10.1186/s12933-020-01087-4
   PubMed Web of Science ®Google Scholar
• Guo L, Zhong L, Chen K, Wu J, Huang RC. Long-term clinical outcomes of optimal medical therapy vs. successful percutaneous coronary intervention for patients with coronary chronic total occlusions. Hellenic J Cardiol. 2018;59(5):281–287. doi:10.1016/j.hjc.2018.03.005
   PubMed Web of Science ®Google Scholar
• Carbone F, Nencioni A, Mach F, Vuilleumier N, Montecucco F. Pathophysiological role of neutrophils in acute myocardial infarction. Thromb Haemost. 2013;110(3):501–514. doi:10.1160/TH13-03-0211
   PubMed Web of Science ®Google Scholar
• Koupenova M, Clancy L, Corkrey HA, Freedman JE. Circulating platelets as mediators of immunity, inflammation, and thrombosis. Circ Res. 2018;122(2):337–351. doi:10.1161/CIRCRESAHA.117.310795
   PubMed Web of Science ®Google Scholar
• Warnatsch A, Ioannou M, Wang Q, Papayannopoulos V. Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science. 2015;349(6245):316–320. doi:10.1126/science.aaa8064
   PubMed Web of Science ®Google Scholar
• Czyz A, Kołacz E, Angerer D, Zawilska K. Expression of activation antigens on lymphocyte surface and circulating platelet-leukocyte aggregates in ischaemic heart disease. Kardiol Pol. 2005;62(3):189–200; discussion 201.
   PubMedGoogle Scholar
• Willim HA, Harianto JC, Cipta H. Platelet-to-lymphocyte ratio at admission as a predictor of in-hospital and long-term outcomes in patients with st-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis. Cardiol Res. 2021;12(2):109–116. doi:10.14740/cr1219
   PubMed Web of Science ®Google Scholar
• He LP, Tang XY, Ling WH, Chen WQ, Chen YM. Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndromes: a meta-analysis of longitudinal studies. Heart. 2010;96(5):339–346. doi:10.1136/hrt.2009.174912
   PubMed Web of Science ®Google Scholar
• Kelesoglu S, Yilmaz Y, Elcık D, Kalay N. Systemic immune inflammation index: a novel predictor for coronary collateral circulation. Perfusion. 2021;37(6):605–612. doi:10.1177/02676591211014822
   PubMed Web of Science ®Google Scholar
• Kelesoglu S, Yilmaz Y, Elcık D, et al. Systemic immune inflammation index: a novel predictor of contrast-induced nephropathy in patients with non-st segment elevation myocardial infarction. Angiology. 2021;72(9):889–895. doi:10.1177/00033197211007738
   PubMed Web of Science ®Google Scholar
• Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336(14):973–979. doi:10.1056/NEJM199704033361401
   PubMed Web of Science ®Google Scholar
• Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119–1131. doi:10.1056/NEJMoa1707914
   PubMed Web of Science ®Google Scholar